Evaluation of efficacy of recombinant Tissue Plasminogen Activator on facility of vitrectomy for diabetic Tractional Retinal Detachment

Phase 3

Recruiting

• Conditions: Diabetic Tractional Retinal Detachment.; Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula; E11.3522

• Registration Number: IRCT20200217046522N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Diabetic Tractional Retinal Detachment
Candidated for vitrectomy

Exclusion Criteria

combined tractional-rhegmatogenous retinal detachment
significant media opacity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anatomical success rate. Timepoint: before surgery, one month and three months after surgery. Method of measurement: clinical examination.

Secondary Outcome Measures

Name	Time	Method
Surgical facility. Timepoint: conclusion of surgery. Method of measurement: Questionnaire.